Results for Schizophrenia

Dr. Anderson’s research interests focus on the molecular and cellular mechanisms that govern the development of the mammalian forebrain. In his research on the development of the cerebral cortex, he is particularly interested in understanding the molecular underpinnings behind the fate determination and axon targeting of subclasses of GABAergic interneurons implicated in the neuropathology of schizophrenia.

Dr. Almasy's work involves statistical genetic studies of addiction, autism, schizophrenia, and related quantitative risk factors.

Dr. Edgar has more than 25 years of experience using non-invasive imaging to study brain function and structure in psychiatric and neurological patient populations. His most recent research focuses on studying brain structure and function maturation processes.

Dr. Taylor's translational and clinical research program focuses on preventing disorders like schizophrenia and bipolar disorder with psychotic features. He is particularly interested in the roles that oxidative stress and neuroinflammation play in psychosis symptom progression in youth.

Dr. Gur's combined training in Psychology, Neurology, and Psychiatry enabled her to pursue an academic career working with basic and clinical neuroscientists to advance the understanding mental disorders.

Dr. Alexander-Bloch investigates normal brain development and the altered developmental trajectories that lead to mental illness. His multi-disciplinary research integrates brain imaging, genomics and clinical information.

Dr. Barzilay aims to understand what drives variability in the development of brain and behavior of youths growing up under stress. He studies biological and environmental mechanisms leading to suicidal behavior, using big datasets of diverse genotyped youths with deep phenotyping of environment.

Dr. Roberts investigates brain-wave scanning with magnetoencephalography (MEG) and works to identify biomarkers for neuropsychiatric disorders like autism. Those biomarkers are for diagnosis, prognosis, stratification, and response monitoring as well as substrate identification for targeted therapy. Putting the "bio" into biomarkers is a major emphasis of Dr. Roberts' research, for which he uses advanced diffusion magnetic resonance imaging (MRI) and edited spectroscopy.